+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

OraSure Technologies Inc (OSUR) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Abaxis Inc
  • Maxim Biomedical Inc
  • MedMira Inc
  • Psychemedics Corp
  • Trinity Biotech Plc
  • MORE
OraSure Technologies Inc (OSUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Critical Information Included
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

OraSure Technologies Inc (OraSure) develops, manufactures and distributes oral fluid diagnostic and collection devices and other diagnostic products for detection and diagnosis of critical medical conditions. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; Ebola virus, Zika virus and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company sells its products through distributors in the Americas, Europe and Asia-Pacific. OraSure is headquartered in Bethlehem, Pennsylvania, the US.

OraSure Technologies Inc Key Recent Developments

Feb 06, 2019: OraSure announces 2018 full year and fourth quarter financial results
Nov 07, 2018: OraSure announces 2018 third quarter financial results
Aug 08, 2018: Orasure announces 2018 second quarter financial results
Jul 23, 2018: OraSure Technologies names vice president, corporate communications
May 04, 2018: OraSure Technologies Names Roberto Cuca As New Chief Financial Officer

Key Benefits

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abaxis Inc
  • Maxim Biomedical Inc
  • MedMira Inc
  • Psychemedics Corp
  • Trinity Biotech Plc
  • MORE
Section 1 - About the Company
  • OraSure Technologies Inc - Key Facts
  • OraSure Technologies Inc - Key Employees
  • OraSure Technologies Inc - Key Employee Biographies
  • OraSure Technologies Inc - Major Products and Services
  • OraSure Technologies Inc - History
  • OraSure Technologies Inc - Company Statement
  • OraSure Technologies Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 – Company Analysis
  • Company Overview
  • OraSure Technologies Inc - Business Description
  • Business Segment: DNAG
  • Overview
  • Performance
  • Business Segment: OSUR
  • Overview
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Other Regions
  • Target Markets
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • OraSure Technologies Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • OraSure Technologies Inc - Strengths
  • OraSure Technologies Inc - Weaknesses
  • OraSure Technologies Inc - Opportunities
  • OraSure Technologies Inc - Threats
  • OraSure Technologies Inc - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • OraSure Technologies Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • OraSure Technologies Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
  • OraSure Technologies Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
  • Feb 06, 2019: OraSure announces 2018 full year and fourth quarter financial results
  • Nov 07, 2018: OraSure announces 2018 third quarter financial results
  • Aug 08, 2018: Orasure announces 2018 second quarter financial results
  • Jul 23, 2018: OraSure Technologies names vice president, corporate communications
  • May 04, 2018: OraSure Technologies Names Roberto Cuca As New Chief Financial Officer
  • May 02, 2018: OraSure Reports 2018 First Quarter Financial Results
  • Apr 10, 2018: OraSure Technologies Appoints New Senior Vice President, Business Development
  • Feb 07, 2018: OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results
  • Feb 02, 2018: OraSure Technologies Names Aradhana Sarin As Board Director
  • Jan 04, 2018: OraSure Technologies Announces Management Succession Plan
Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • OraSure Technologies Inc, Key Facts
  • OraSure Technologies Inc, Key Employees
  • OraSure Technologies Inc, Key Employee Biographies
  • OraSure Technologies Inc, Major Products and Services
  • OraSure Technologies Inc, History
  • OraSure Technologies Inc, Other Locations
  • OraSure Technologies Inc, Subsidiaries
  • OraSure Technologies Inc, Key Competitors
  • OraSure Technologies Inc, Ratios based on current share price
  • OraSure Technologies Inc, Annual Ratios
  • OraSure Technologies Inc, Interim Ratios
  • OraSure Technologies Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • OraSure Technologies Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
  • OraSure Technologies Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • OraSure Technologies Inc, Performance Chart (2014 - 2018)
  • OraSure Technologies Inc, Ratio Charts
  • OraSure Technologies Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • OraSure Technologies Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Trinity Biotech Plc
  • Psychemedics Corp
  • MedMira Inc
  • Maxim Biomedical Inc
  • Abaxis Inc
Note: Product cover images may vary from those shown
Adroll
adroll